Anthony Hawkridge Selected Research

AERAS-402

1/2016	Adenovirus type 35-vectored tuberculosis vaccine has an acceptable safety and tolerability profile in healthy, BCG-vaccinated, QuantiFERON(®)-TB Gold (+) Kenyan adults without evidence of tuberculosis.
6/2010	The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anthony Hawkridge Research Topics

Disease

14	Tuberculosis (Tuberculoses) 05/2016 - 10/2006
4	Infections 01/2016 - 01/2009
1	Hepatitis B 01/2016
1	Human Influenza (Influenza) 01/2016
1	Neutropenia 01/2016
1	Pain (Aches) 01/2016
1	Vaccine-Preventable Diseases 08/2011
1	Vaccinia 01/2010

Drug/Important Bio-Agent (IBA)

12	VaccinesIBA 05/2016 - 10/2006
2	Tuberculosis VaccinesIBA 01/2016 - 01/2010
2	AERAS-402IBA 01/2016 - 06/2010
2	MVA 85AIBA 04/2012 - 01/2010
2	BCG Vaccine FDA Link 08/2011 - 11/2008
2	CytokinesIBA 10/2010 - 03/2008
1	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2016
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2016
1	GoldIBA 01/2016
1	Immunodominant EpitopesIBA 01/2016
1	Tuberculin (PPD)IBA 01/2009
1	EnzymesIBA 01/2009